Skip to Content

SEC Filings

Filing date	Form	Description	View
Jan 27, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-003422.pdf 0000899243-22-003422.rtf 0000899243-22-003422.xls View HTML
Jan 25, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-003136.pdf 0000899243-22-003136.rtf 0000899243-22-003136.xls View HTML
Jan 25, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-003143.pdf 0000899243-22-003143.rtf 0000899243-22-003143.xls View HTML
Jan 20, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-002634.pdf 0000899243-22-002634.rtf 0000899243-22-002634.xls View HTML
Jan 18, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-002118.pdf 0000899243-22-002118.rtf 0000899243-22-002118.xls View HTML
Jan 13, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-001895.pdf 0000899243-22-001895.rtf 0000899243-22-001895.xls View HTML
Jan 12, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-001744.pdf 0000899243-22-001744.rtf 0000899243-22-001744.xls View HTML
Jan 10, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-001470.pdf 0000899243-22-001470.rtf 0000899243-22-001470.xls View HTML
Jan 04, 2022	4	Statement of changes in beneficial ownership of securities	0000899243-22-000473.pdf 0000899243-22-000473.rtf 0000899243-22-000473.xls View HTML
Nov 04, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-21-054518.pdf 0001564590-21-054518.rtf 0001564590-21-054518.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.